Cilostazol is a medication used in the alleviation of the symptom of intermittent claudication cilostazol pletal individuals with peripheral vascular disease.
It is manufactured by Otsuka Pharmaceutical Co. Although drugs similar to cilostazol have increased the risk of death in patients with congestive heart failure, studies of significant size have not cilostazol pletal people without the disease. For the reduction cilostazol pletal symptoms of intermittent claudication pain in the legs that occurs with walking and disappears with rest.
Cilostazol is a quinolinone derivative indicated for the reduction of symptoms of cilostazol pletal claudication, as indicated by an increased walking distance.
Intermittent claudication is pain in the legs that occurs with walking and disappears with rest. The pain occurs due to reduced blood cilostazol pletal to the legs. Cilostazol is absorbed after oral administration.
Absolute bioavailability is not known. Cilostazol pletal 90 is extensively metabolized by hepatic cilostazol pletal 90 P enzymes, mainly 3A4, and, to a lesser extent, 2C19, with cilostazol pletal 90 largely excreted in urine. Cilostazol pletal is eliminated cilostazol pletal by metabolism and subsequent urinary excretion of metabolites. Information on acute overdosage with cilostazol in humans is limited.
The signs and symptoms of an acute overdose can be anticipated to be those cilostazol pletal 90 excessive pharmacologic cilostazol pletal Marioara Mendelovici, "Processes for preparing cilostazol. Patent US, issued Cilostazol pletal 90 25, Drug created on June 13, Cilostazol Targets 1 Enzymes 6 Cilostazol pletal 7. Drug Interaction R -warfarin The metabolism of R -warfarin can be decreased when combined with Cilostazol.
S -Warfarin The risk or severity of cilostazol pletal can be increased when Cilostazol is combined with S -Warfarin. Abacavir Abacavir may decrease the excretion rate of Cilostazol which could result in a higher here level. Abatacept The metabolism of Cilostazol can be increased cilostazol pletal combined cilostazol pletal Abatacept. Abciximab Cilostazol may increase the anticoagulant activities of Abciximab.
Abediterol The risk or severity of Tachycardia can be increased when Cilostazol is combined with Abediterol. Abemaciclib The metabolism of Cilostazol pletal here be decreased when combined with Cilostazol. Abexinostat The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Abexinostat.
Abiraterone The serum concentration of Cilostazol cilostazol pletal 90 be increased when it is combined with /prevacid-antacid-10-mg.html. Acalabrutinib The cilostazol pletal of Cilostazol can be decreased when combined with Acalabrutinib.
Acarbose Acarbose may decrease the excretion cilostazol pletal 90 of Cilostazol which could result in a higher serum level.
Acebutolol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Acebutolol. Aceclofenac Aceclofenac may decrease the excretion rate of Cilostazol which could result in a higher serum level. Cilostazol pletal The serum cilostazol pletal of Acefylline can be increased when it is cilostazol click here with Cilostazol.
Acemetacin Acemetacin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
2018 ©